BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35725801)

  • 21. Cytotoxic effects of the components in heat-treated mistletoe (Viscum album).
    Park JH; Hyun CK; Shin HK
    Cancer Lett; 1999 May; 139(2):207-13. PubMed ID: 10395180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
    Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
    Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of viscotoxins with vesicles of genuine plant membranes.
    Winkler K; Jäger S; Leneweit G; Schubert R
    Planta Med; 2008 Feb; 74(2):163-7. PubMed ID: 18203060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and partial characterization of a small chitin-binding lectin from mistletoe (Viscum album).
    Peumans WJ; Verhaert P; Pfüller U; Van Damme EJ
    FEBS Lett; 1996 Nov; 396(2-3):261-5. PubMed ID: 8914999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete structure determination of the A chain of mistletoe lectin III from Viscum album L. ssp. album.
    Wacker R; Stoeva S; Pfüller K; Pfüller U; Voelter W
    J Pept Sci; 2004 Mar; 10(3):138-48. PubMed ID: 15113086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystallization of the ribosome inactivating protein ML1 from Viscum album (mistletoe) complexed with beta-D-galactose.
    Sweeney EC; Palmer RA; Pfüller U
    J Mol Biol; 1993 Dec; 234(4):1279-81. PubMed ID: 8263931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection and quantitative determination of lectins and viscotoxins in mistletoe preparations].
    Jordan E; Wagner H
    Arzneimittelforschung; 1986 Mar; 36(3):428-33. PubMed ID: 3707660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins.
    Büssing A; Schietzel M
    Anticancer Res; 1999; 19(1A):23-8. PubMed ID: 10226520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thionins from Viscum album L: influence of the viscotoxins on the activation of granulocytes.
    Stein GM; Schaller G; Pfüller U; Schietzel M; Büssing A
    Anticancer Res; 1999; 19(2A):1037-42. PubMed ID: 10368652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and properties of polysaccharides from Viscum album (L.).
    Jordan E; Wagner H
    Oncology; 1986; 43 Suppl 1():8-15. PubMed ID: 3808577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR structural determination of viscotoxin A3 from Viscum album L.
    Romagnoli S; Ugolini R; Fogolari F; Schaller G; Urech K; Giannattasio M; Ragona L; Molinari H
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):569-77. PubMed ID: 10947973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

  • 34. Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells.
    Kim MS; So HS; Lee KM; Park JS; Lee JH; Moon SK; Ryu DG; Chung SY; Jung BH; Kim YK; Moon G; Park R
    Gen Pharmacol; 2000 May; 34(5):349-55. PubMed ID: 11368891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary structure and molecular modeling of mistletoe lectin I from Viscum album.
    Eschenburg S; Krauspenhaar R; Mikhailov A; Stoeva S; Betzel C; Voelter W
    Biochem Biophys Res Commun; 1998 Jun; 247(2):367-72. PubMed ID: 9642133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of alginate/chitosan microcapsules and enteric coated granules of mistletoe lectin.
    Lyu SY; Kwon YJ; Joo HJ; Park WB
    Arch Pharm Res; 2004 Jan; 27(1):118-26. PubMed ID: 14969350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.
    Stettin A; Schultze JL; Stechemesser E; Berg PA
    Klin Wochenschr; 1990 Sep; 68(18):896-900. PubMed ID: 2124308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
    Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
    Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mistletoe lectin I--phloretamide structure reveals a new function of plant lectins.
    Meyer A; Rypniewski W; Celewicz L; Erdmann VA; Voelter W; Singh TP; Genov N; Barciszewski J; Betzel Ch
    Biochem Biophys Res Commun; 2007 Dec; 364(2):195-200. PubMed ID: 17937929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins.
    Frantz M; Jung ML; Ribereau-Gayon G; Anton R
    Arzneimittelforschung; 2000 May; 50(5):471-8. PubMed ID: 10858875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.